| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Severe Combined Immunodeficiency | 7 | 2018 | 104 | 0.940 |
Why?
|
| Granuloma | 2 | 2021 | 63 | 0.600 |
Why?
|
| Bronchiectasis | 1 | 2019 | 22 | 0.600 |
Why?
|
| Granulomatous Disease, Chronic | 5 | 2020 | 70 | 0.580 |
Why?
|
| DiGeorge Syndrome | 6 | 2015 | 79 | 0.570 |
Why?
|
| Sinusitis | 1 | 2019 | 117 | 0.550 |
Why?
|
| B-Lymphocytes | 3 | 2018 | 516 | 0.490 |
Why?
|
| Killer Cells, Natural | 3 | 2016 | 333 | 0.490 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2016 | 74 | 0.480 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 479 | 0.440 |
Why?
|
| Leprosy, Tuberculoid | 1 | 2014 | 7 | 0.440 |
Why?
|
| Molluscum Contagiosum | 1 | 2014 | 11 | 0.440 |
Why?
|
| Epidermodysplasia Verruciformis | 1 | 2014 | 13 | 0.440 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 7 | 2023 | 1167 | 0.430 |
Why?
|
| Mucous Membrane | 1 | 2014 | 86 | 0.430 |
Why?
|
| Immunologic Deficiency Syndromes | 5 | 2021 | 209 | 0.400 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 269 | 0.380 |
Why?
|
| Skin | 1 | 2014 | 517 | 0.350 |
Why?
|
| Skin Tests | 3 | 2025 | 100 | 0.320 |
Why?
|
| Cord Blood Stem Cell Transplantation | 2 | 2023 | 53 | 0.320 |
Why?
|
| Common Variable Immunodeficiency | 2 | 2008 | 31 | 0.320 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 385 | 0.320 |
Why?
|
| Lymphopenia | 2 | 2023 | 33 | 0.310 |
Why?
|
| Immunoglobulin E | 3 | 2025 | 220 | 0.310 |
Why?
|
| Transplantation Conditioning | 3 | 2017 | 304 | 0.300 |
Why?
|
| Rubella | 2 | 2021 | 18 | 0.290 |
Why?
|
| Brain Abscess | 1 | 2008 | 53 | 0.280 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2006 | 9 | 0.250 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2006 | 21 | 0.240 |
Why?
|
| T-Lymphocytes | 5 | 2009 | 1712 | 0.230 |
Why?
|
| Spirometry | 2 | 2022 | 84 | 0.230 |
Why?
|
| Antigens, Plant | 1 | 2025 | 45 | 0.220 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 565 | 0.200 |
Why?
|
| Peanut Hypersensitivity | 1 | 2025 | 86 | 0.200 |
Why?
|
| Epitopes | 1 | 2025 | 421 | 0.200 |
Why?
|
| Autoimmune Diseases | 2 | 2018 | 269 | 0.190 |
Why?
|
| Rubella virus | 1 | 2021 | 5 | 0.180 |
Why?
|
| Humans | 39 | 2025 | 127501 | 0.180 |
Why?
|
| Racism | 1 | 2022 | 42 | 0.170 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 154 | 0.170 |
Why?
|
| Neutrophils | 2 | 2021 | 355 | 0.170 |
Why?
|
| Unrelated Donors | 2 | 2018 | 72 | 0.160 |
Why?
|
| Health Equity | 1 | 2022 | 76 | 0.160 |
Why?
|
| Allergens | 2 | 2025 | 346 | 0.160 |
Why?
|
| Mutation | 4 | 2018 | 5950 | 0.150 |
Why?
|
| Child | 18 | 2025 | 25302 | 0.140 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2018 | 47 | 0.140 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2018 | 32 | 0.140 |
Why?
|
| Cough | 1 | 2019 | 97 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2022 | 396 | 0.140 |
Why?
|
| Child, Preschool | 14 | 2025 | 14467 | 0.140 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2017 | 23 | 0.140 |
Why?
|
| Alemtuzumab | 1 | 2018 | 87 | 0.140 |
Why?
|
| Female | 21 | 2025 | 68765 | 0.140 |
Why?
|
| Infant | 13 | 2025 | 12811 | 0.130 |
Why?
|
| Macrophages | 1 | 2021 | 643 | 0.130 |
Why?
|
| Male | 22 | 2025 | 62895 | 0.130 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2017 | 14 | 0.130 |
Why?
|
| Leukopenia | 1 | 2017 | 44 | 0.130 |
Why?
|
| Adolescent | 13 | 2025 | 20156 | 0.130 |
Why?
|
| rab27 GTP-Binding Proteins | 1 | 2016 | 5 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 113 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 584 | 0.120 |
Why?
|
| Polymorphism, Genetic | 2 | 2018 | 788 | 0.110 |
Why?
|
| Food Hypersensitivity | 1 | 2018 | 177 | 0.110 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2014 | 25 | 0.110 |
Why?
|
| Chickenpox | 1 | 2014 | 22 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 1206 | 0.110 |
Why?
|
| Chromosome Disorders | 1 | 2017 | 315 | 0.110 |
Why?
|
| Inflammation | 1 | 2021 | 1435 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2025 | 2080 | 0.110 |
Why?
|
| Telomere Shortening | 1 | 2014 | 34 | 0.110 |
Why?
|
| Osteomyelitis | 2 | 2007 | 208 | 0.100 |
Why?
|
| Asthma | 1 | 2022 | 899 | 0.100 |
Why?
|
| Siblings | 1 | 2014 | 202 | 0.100 |
Why?
|
| Immunologic Memory | 1 | 2014 | 194 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2021 | 3596 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 784 | 0.090 |
Why?
|
| Heterozygote | 1 | 2014 | 691 | 0.090 |
Why?
|
| Cognition | 1 | 2017 | 806 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2016 | 890 | 0.090 |
Why?
|
| Lymphocyte Count | 3 | 2009 | 117 | 0.080 |
Why?
|
| Autoimmunity | 1 | 2011 | 172 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 1892 | 0.080 |
Why?
|
| Rotavirus Vaccines | 1 | 2010 | 60 | 0.080 |
Why?
|
| Vaccination | 1 | 2014 | 1003 | 0.080 |
Why?
|
| Hematopoietic System | 1 | 2008 | 6 | 0.070 |
Why?
|
| Adenylate Kinase | 1 | 2008 | 12 | 0.070 |
Why?
|
| Interleukin-7 | 1 | 2009 | 45 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2021 | 638 | 0.070 |
Why?
|
| Antigens, Fungal | 1 | 2008 | 34 | 0.070 |
Why?
|
| Tetanus Toxoid | 1 | 2008 | 48 | 0.070 |
Why?
|
| HIV Infections | 2 | 1997 | 1954 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2016 | 1569 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2008 | 215 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2008 | 116 | 0.070 |
Why?
|
| Candida | 1 | 2008 | 79 | 0.070 |
Why?
|
| ROC Curve | 2 | 2021 | 592 | 0.070 |
Why?
|
| Basidiomycota | 1 | 2007 | 11 | 0.070 |
Why?
|
| Adult | 9 | 2018 | 30603 | 0.070 |
Why?
|
| Rotavirus Infections | 1 | 2010 | 278 | 0.070 |
Why?
|
| Rotavirus | 1 | 2010 | 363 | 0.070 |
Why?
|
| CD3 Complex | 2 | 2008 | 91 | 0.070 |
Why?
|
| Phenotype | 1 | 2017 | 4309 | 0.070 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2008 | 155 | 0.060 |
Why?
|
| Middle Aged | 4 | 2021 | 27886 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2021 | 4987 | 0.060 |
Why?
|
| Allografts | 2 | 2017 | 189 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 313 | 0.060 |
Why?
|
| Radioallergosorbent Test | 1 | 2006 | 9 | 0.060 |
Why?
|
| Phytohemagglutinins | 2 | 2003 | 12 | 0.060 |
Why?
|
| Mycoses | 1 | 2007 | 112 | 0.060 |
Why?
|
| Burkholderia gladioli | 1 | 2005 | 2 | 0.060 |
Why?
|
| Burkholderia Infections | 1 | 2005 | 8 | 0.060 |
Why?
|
| Cytokines | 2 | 2021 | 1326 | 0.060 |
Why?
|
| 2S Albumins, Plant | 1 | 2025 | 6 | 0.060 |
Why?
|
| Radiography | 2 | 2017 | 755 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 900 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 475 | 0.060 |
Why?
|
| Arachis | 1 | 2025 | 75 | 0.050 |
Why?
|
| Th2 Cells | 2 | 2021 | 186 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 808 | 0.050 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2023 | 12 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 3271 | 0.050 |
Why?
|
| src Homology Domains | 1 | 2023 | 35 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2025 | 6247 | 0.050 |
Why?
|
| Busulfan | 1 | 2023 | 46 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2003 | 50 | 0.050 |
Why?
|
| CD8 Antigens | 1 | 2003 | 40 | 0.050 |
Why?
|
| Immunization | 1 | 2004 | 304 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2025 | 338 | 0.050 |
Why?
|
| Survival Rate | 2 | 2017 | 2110 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 220 | 0.050 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2021 | 25 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 899 | 0.050 |
Why?
|
| Forced Expiratory Volume | 1 | 2022 | 168 | 0.050 |
Why?
|
| Cross-Cultural Comparison | 1 | 2022 | 57 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 687 | 0.040 |
Why?
|
| Cell Division | 1 | 2003 | 719 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 2001 | 25 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2004 | 313 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 2001 | 36 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 5161 | 0.040 |
Why?
|
| Job Syndrome | 1 | 2001 | 18 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2022 | 220 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2008 | 2400 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 424 | 0.040 |
Why?
|
| Chemokines | 1 | 2001 | 127 | 0.040 |
Why?
|
| Arginine | 1 | 2023 | 335 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 303 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 278 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2021 | 392 | 0.040 |
Why?
|
| DNA Copy Number Variations | 2 | 2016 | 1005 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 288 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2240 | 0.040 |
Why?
|
| Pedigree | 2 | 2016 | 1656 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2018 | 8372 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 1436 | 0.040 |
Why?
|
| Complement Hemolytic Activity Assay | 1 | 1998 | 1 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2021 | 473 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2018 | 156 | 0.040 |
Why?
|
| Immunologic Tests | 1 | 1998 | 17 | 0.040 |
Why?
|
| Chimerism | 1 | 2018 | 28 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 1601 | 0.040 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1998 | 32 | 0.040 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 30 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 327 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 1998 | 66 | 0.030 |
Why?
|
| Pancytopenia | 1 | 2018 | 40 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2018 | 181 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1998 | 100 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 459 | 0.030 |
Why?
|
| Communication | 1 | 2022 | 513 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1998 | 156 | 0.030 |
Why?
|
| Machine Learning | 1 | 2021 | 325 | 0.030 |
Why?
|
| Young Adult | 3 | 2018 | 9702 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 372 | 0.030 |
Why?
|
| Adenylyl Cyclases | 1 | 2017 | 60 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2017 | 17080 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 2017 | 136 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1997 | 131 | 0.030 |
Why?
|
| Phagocytosis | 1 | 1998 | 191 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2017 | 87 | 0.030 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 303 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1235 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 20512 | 0.030 |
Why?
|
| Piebaldism | 1 | 2016 | 3 | 0.030 |
Why?
|
| Albinism | 1 | 2016 | 8 | 0.030 |
Why?
|
| Micronutrients | 1 | 1996 | 61 | 0.030 |
Why?
|
| Sepsis | 1 | 2020 | 494 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 793 | 0.030 |
Why?
|
| Consanguinity | 1 | 2016 | 118 | 0.030 |
Why?
|
| Age of Onset | 1 | 2017 | 611 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2016 | 184 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2015 | 10 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 265 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2017 | 560 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 10636 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 399 | 0.030 |
Why?
|
| Immunological Synapses | 1 | 2015 | 32 | 0.030 |
Why?
|
| Integrins | 1 | 2015 | 88 | 0.030 |
Why?
|
| Nutritional Status | 1 | 1996 | 299 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 224 | 0.030 |
Why?
|
| United States | 2 | 2022 | 11425 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 1054 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2015 | 258 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1524 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2021 | 781 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 769 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2017 | 643 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3332 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2001 | 2313 | 0.020 |
Why?
|
| Texas | 1 | 2021 | 3564 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1997 | 1868 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 1664 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 2125 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 1008 | 0.020 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 672 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 3261 | 0.020 |
Why?
|
| Diarrhea, Infantile | 1 | 2010 | 31 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1374 | 0.020 |
Why?
|
| Dehydration | 1 | 2010 | 40 | 0.020 |
Why?
|
| Virus Shedding | 1 | 2010 | 75 | 0.020 |
Why?
|
| Exome | 1 | 2014 | 1064 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2010 | 88 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7426 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2009 | 205 | 0.020 |
Why?
|
| Ear, Inner | 1 | 2008 | 41 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2010 | 448 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 586 | 0.020 |
Why?
|
| Genomics | 1 | 2016 | 1549 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 231 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 236 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2010 | 511 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2008 | 196 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 349 | 0.020 |
Why?
|
| Sacrum | 1 | 2007 | 27 | 0.020 |
Why?
|
| Voriconazole | 1 | 2007 | 31 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2007 | 33 | 0.020 |
Why?
|
| HMGB1 Protein | 1 | 2007 | 25 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2007 | 46 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1232 | 0.020 |
Why?
|
| Echinocandins | 1 | 2007 | 42 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 1055 | 0.020 |
Why?
|
| Triazoles | 1 | 2007 | 130 | 0.020 |
Why?
|
| Feces | 1 | 2010 | 702 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 421 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2007 | 296 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2009 | 632 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 2623 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2007 | 407 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 1709 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2005 | 382 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 2566 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2004 | 330 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 429 | 0.010 |
Why?
|
| Animals | 2 | 2018 | 33212 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 755 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2009 | 12583 | 0.010 |
Why?
|
| Chemokine CXCL5 | 1 | 2001 | 5 | 0.010 |
Why?
|
| Chemokine CCL7 | 1 | 2001 | 7 | 0.010 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2001 | 7 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 2001 | 12 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2001 | 59 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 2001 | 42 | 0.010 |
Why?
|
| Receptor, trkA | 1 | 2001 | 15 | 0.010 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2001 | 19 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1871 | 0.010 |
Why?
|
| Osteopontin | 1 | 2001 | 51 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2001 | 124 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 435 | 0.010 |
Why?
|
| Interleukins | 1 | 2001 | 119 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2001 | 154 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2001 | 204 | 0.010 |
Why?
|
| Quality of Life | 1 | 2009 | 2032 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2001 | 528 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 2999 | 0.010 |
Why?
|
| Vitamin A Deficiency | 1 | 1996 | 11 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 2901 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2001 | 2542 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1996 | 183 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 3937 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 2519 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 17695 | 0.010 |
Why?
|